ESC 365 - Vasodilators in acute heart failure – The end of the beginning or the beginning of the end. Introduction.

HFA Premium Access

Vasodilators in acute heart failure – The end of the beginning or the beginning of the end. Introduction.

Session: The Grand Debate 1: Neprilysin inhibitor - Vasodilators - Vasodilators in acute heart failure

Topic: Acute heart failure (therapy)

Speaker: Professor G. Filippatos (Athens, GR)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)

80 presentations

14 followers

5 more presentations in this session

Vasodilators in acute heart failure: the end of the beginning.

Speaker: Professor M. Packer (Dallas, US)

Vasodilators in acute heart failure: the beginning of the end.

Speaker: Professor A. Mebazaa (Paris, FR)

Rebuttal - PRO - by M Packer.

Rebuttal - CONTRA - by A Mebazaa.

Grand finale.

Access the full session

The Grand Debate 1: Neprilysin inhibitor - Vasodilators - Vasodilators in acute heart failure

Speakers: Professor G. Filippatos, Professor M. Packer, Professor A. Mebazaa

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources